Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
07/2000
07/18/2000US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
07/18/2000US6090841 Antiallergens, antiinflammatory agents
07/18/2000US6090809 1-(4-arylpiperazin-1-yl)-ω-[n-(α..omega.-dicarboximido)]-alkanes useful as uro-selective α1 -adrenoceptor blockers
07/18/2000US6090787 Antithrombotic agents
07/18/2000US6090786 Serine proteases, their activity and their synthetic inhibitors
07/18/2000US6090250 Chiral surfactants and methods for their use in chiral separations
07/18/2000CA2008616C Aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
07/13/2000WO2000040558A1 Aspartic protease inhibitors
07/13/2000WO2000040553A1 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases
07/13/2000WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors
07/13/2000WO2000003737A9 Water-soluble drugs and methods for their production
07/13/2000CA2356969A1 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases
07/12/2000EP1018008A2 Method of identification of leads or active compounds
07/12/2000EP1017734A1 Crosslinkable polyurea polymers
07/12/2000EP1017658A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia
07/12/2000EP0720600B1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
07/12/2000EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies
07/12/2000CN1260006A Complex formation between dsDNA and oligomer of heterocycles
07/12/2000CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same
07/12/2000CN1054369C Novel processes for preparing (S)-4-amino-hepta-5,6-dienoic acid and intermediates thereof
07/11/2000US6087511 Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid) calcium salt (2:1)
07/11/2000US6087379 Cyclic amine derivatives
07/11/2000CA2030519C Acryloyl substituted pyrrole derivatives
07/06/2000WO2000039086A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
07/06/2000WO2000039085A1 Process for the production of n-vinyl-2-pyrrolidone by vinylation
07/06/2000WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/06/2000WO2000039077A2 Thyroid receptor ligands
07/06/2000WO2000038680A1 Azabicycloalkanes as ccr5 modulators
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2356319A1 Thyroid receptor ligands
07/06/2000CA2353961A1 Heteroaromatic derivatives having an inhibitory activity against hiv integrase
07/05/2000EP1016659A1 Bismaleimides comprising mesogenic groups and oligomeric liquid crystalline bismaleimides
07/05/2000EP1015454A1 Method of inhibiting serine protease enzymes
07/05/2000EP1015428A1 Sulfo-n-hydroxy succinimide and method of preparation
07/05/2000EP1015427A1 Substituted 2-pyrrolidinone activators of pkc
07/05/2000EP1015405A1 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof
07/05/2000EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
07/05/2000EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
07/05/2000EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
07/05/2000CN1259122A Method for producing chiral 3,4-dehydroprolines
07/05/2000CN1259121A Novel sulfonamide derivatives
07/05/2000CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use
07/04/2000US6084120 β-Alkoxyacrylates against malaria
07/04/2000US6084097 Methods for preparing 1-[4-arylpiperazin-1-yl]-3-[2-oxopyrrolidin/piperidin-1-yl] propanes
07/04/2000US6083965 Antiparasitic agents
07/04/2000US6083950 Treatment of peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy
07/04/2000US6083943 For treatment of gastrointestinal disorders, central nervous system disorders, allergy, inflammatory diseases, asthma, pain, emesis or migraine in mammals, especially humans
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
06/2000
06/29/2000WO2000037478A1 Ligands and complexes for enantioselective hydrogenation
06/29/2000WO2000037434A1 Amide derivatives
06/29/2000WO2000037430A2 Use of androgen receptor suppressors
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037074A1 Mutilin 14-ester derivatives having antibacterial activity
06/29/2000WO2000037024A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
06/29/2000WO2000009112A3 Heterocyclic esters or amides for vision and memory disorders
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE19859684A1 Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole A process for preparing fluorine-containing phenethylamines and new, fluorine enthalende beta-iminovinyl- and beta-iminoethylbenzenes
06/28/2000EP1014186A1 Photographic yellow dye-forming couplers
06/28/2000EP1013646A1 Process for the Synthesis of 2,4-Dimethyl-3,5-bis-alkoxy-carbonyl-pyrrole
06/28/2000EP1013645A1 Process for the preparation of 2,4-dimethyl-pyrrole
06/28/2000EP1013637A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000EP1012131A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
06/28/2000CN1258275A Process for preparing 3-(7-amidino-2-naphthyl) 2-phenylpropionic acid derivs.
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080749 For controlling fungus pests
06/23/2000CA2292851A1 Process for preparing fluorine-containing phenethylamines and novel fluorine-containing .beta.-iminovinyl-and .beta.-iminoethylbenzenes
06/22/2000WO2000035876A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
06/22/2000WO2000035871A1 Lactams
06/22/2000WO2000035870A1 Process for the production of optically active 3,4-dehydroprolines
06/22/2000WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035857A1 Multifunctional imine-esters as novel crosslinkers for surface coatings
06/22/2000WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035435A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000WO2000006620A3 Polymerization of olefins
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2353151A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments
06/22/2000CA2350730A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2348923A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347909A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347769A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
06/22/2000CA2346933A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2346684A1 Use of a mek inhibitor for preventing transplant rejection
06/21/2000EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them